PANCREATIC CANCER, ADULT
Clinical trials for PANCREATIC CANCER, ADULT explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADULT trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Special nutrition drink tested to help pancreatic cancer patients recover after surgery
Disease control Recruiting nowThis study is testing which of two liquid nutrition formulas works better for pancreatic cancer patients who are malnourished or at risk after major surgery. Researchers will compare a specialized formula (Peptamen 1.6) against a standard high-protein formula in 20 patients. They…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: NA • Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Genetic clues may predict pancreatic cancer treatment success
Disease control Recruiting nowThis study is testing whether genetic analysis of pancreatic tumors can predict how well patients respond to chemotherapy before surgery. Researchers will give 45 patients with non-metastatic pancreatic cancer a standard chemotherapy combination called FOLFIRINOX, then analyze tu…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for tough cancer: Four-Drug attack on pancreatic tumors
Disease control Recruiting nowThis study is testing a new combination of four drugs as a first treatment for adults with advanced pancreatic cancer that cannot be surgically removed. The goal is to see if adding two newer drugs (adebrelimab and chidamide) to two standard chemotherapy drugs can better control …
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE2 • Sponsor: Liu Xiufeng • Aim: Disease control
Last updated Feb 23, 2026 14:54 UTC
-
Breakthrough blood test trial aims to catch deadly pancreatic cancer early in High-Risk group
Diagnosis Recruiting nowThis study is testing a new blood test called Avantect to see if it can find pancreatic cancer early in people who were recently diagnosed with type 2 diabetes, as they have a higher risk. About 15,000 participants will be randomly assigned to either get the test now or later, an…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: NA • Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
AI blood test could revolutionize cancer detection
Diagnosis Recruiting nowThis study aims to develop and test a new blood test that uses artificial intelligence to detect cancer early and monitor how well treatment is working. Researchers will analyze RNA from blood cells in 6,000 participants, including people with 8 common cancers and healthy individ…
Matched conditions: PANCREATIC CANCER, ADULT
Sponsor: Javier Toledo • Aim: Diagnosis
Last updated Mar 24, 2026 12:01 UTC
-
New blood test could spot deadly pancreatic cancer sooner
Diagnosis Recruiting nowThis study aims to confirm if a new blood test can find pancreatic cancer at its earliest, most treatable stages. Researchers will test the method in 2,000 people, including those with and without pancreatic cancer. The test looks for tiny genetic signals in the blood that may in…
Matched conditions: PANCREATIC CANCER, ADULT
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Mar 23, 2026 15:18 UTC